223 related articles for article (PubMed ID: 16857285)
1. Functional lentiviral vectors for xeroderma pigmentosum gene therapy.
Marchetto MC; Correa RG; Menck CF; Muotri AR
J Biotechnol; 2006 Dec; 126(4):424-30. PubMed ID: 16857285
[TBL] [Abstract][Full Text] [Related]
2. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
[TBL] [Abstract][Full Text] [Related]
3. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.
Armelini MG; Muotri AR; Marchetto MC; de Lima-Bessa KM; Sarasin A; Menck CF
Cancer Gene Ther; 2005 Apr; 12(4):389-96. PubMed ID: 15650764
[TBL] [Abstract][Full Text] [Related]
4. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
5. Exploring DNA damage responses in human cells with recombinant adenoviral vectors.
Armelini MG; Lima-Bessa KM; Marchetto MC; Muotri AR; Chiganças V; Leite RA; Carvalho H; Menck CF
Hum Exp Toxicol; 2007 Nov; 26(11):899-906. PubMed ID: 18042584
[TBL] [Abstract][Full Text] [Related]
6. Differential behaviors toward ultraviolet A and B radiation of fibroblasts and keratinocytes from normal and DNA-repair-deficient patients.
Otto AI; Riou L; Marionnet C; Mori T; Sarasin A; Magnaldo T
Cancer Res; 1999 Mar; 59(6):1212-8. PubMed ID: 10096550
[TBL] [Abstract][Full Text] [Related]
7. The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect.
Berneburg M; Clingen PH; Harcourt SA; Lowe JE; Taylor EM; Green MH; Krutmann J; Arlett CF; Lehmann AR
Cancer Res; 2000 Jan; 60(2):431-8. PubMed ID: 10667598
[TBL] [Abstract][Full Text] [Related]
8. Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice.
Marchetto MC; Muotri AR; Burns DK; Friedberg EC; Menck CF
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17759-64. PubMed ID: 15598745
[TBL] [Abstract][Full Text] [Related]
9. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
[TBL] [Abstract][Full Text] [Related]
11. Retrovirus-mediated DNA repair gene transfer into xeroderma pigmentosum cells: perspectives for a gene therapy.
Zeng L; Sarasin A; Mezzina M
Cell Biol Toxicol; 1998 Mar; 14(2):105-10. PubMed ID: 9553721
[TBL] [Abstract][Full Text] [Related]
12. A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients.
Terleth C; van Laar T; Schouten R; van Steeg H; Hodemaekers H; Wormhoudt T; Cornelissen-Steijger PD; Abrahams PJ; van der Eb AJ
Cancer Res; 1997 Oct; 57(19):4384-92. PubMed ID: 9331102
[TBL] [Abstract][Full Text] [Related]
13. Development of new EBV-based vectors for stable expression of small interfering RNA to mimick human syndromes: application to NER gene silencing.
Biard DS; Despras E; Sarasin A; Angulo JF
Mol Cancer Res; 2005 Sep; 3(9):519-29. PubMed ID: 16179499
[TBL] [Abstract][Full Text] [Related]
14. Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C.
Legerski R; Peterson C
Nature; 1992 Sep; 359(6390):70-3. PubMed ID: 1522891
[TBL] [Abstract][Full Text] [Related]
15. Xeroderma pigmentosum.
Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
[TBL] [Abstract][Full Text] [Related]
16. Reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro: a model to study hypersensitivity to UV light.
Bernerd F; Asselineau D; Frechet M; Sarasin A; Magnaldo T
Photochem Photobiol; 2005; 81(1):19-24. PubMed ID: 15369409
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
Sugasawa K
Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus mediated transduction of the human DNA polymerase eta cDNA.
Lima-Bessa KM; Chiganças V; Stary A; Kannouche P; Sarasin A; Armelini MG; de Fátima Jacysyn J; Amarante-Mendes GP; Cordeiro-Stone M; Cleaver JE; Menck CF
DNA Repair (Amst); 2006 Aug; 5(8):925-34. PubMed ID: 16798111
[TBL] [Abstract][Full Text] [Related]
20. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
Magnaldo T; Sarasin A
Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]